Bihar Conclave 2025

Pharmaceutical Industry

The Indian pharmaceutical industry has been exempted from the US tariff hike, announced by President Trump on 27 August, after raising India-related tariffs to 50% on Russian oil purchases.

India’s pharma exports hit $5 billion in April-May FY26, with strong growth in formulations, vaccines, and global demand, says Pharmexcil.

India’s pharmaceutical sector continues to rise on the global stage, driven by innovation, affordability, and inclusivity.

India’s pharmaceutical exports surged to an all-time high of $30.47 billion (£24.5 billion approx.) in the financial year 2024–25.

The domestic pharmaceutical sector is anticipated to see revenue growth of 6–8% in the upcoming fiscal year.